Sami Corwin
Stock Analyst at William Blair
(4.80)
# 501
Out of 4,442 analysts
407
Total ratings
56.9%
Success rate
18.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Reiterated: Buy | n/a | $30.06 | - | 10 | Jun 10, 2026 | |
| NGNE Neurogene | Maintained: Buy | n/a | $30.86 | - | 23 | Jun 8, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | n/a | $13.00 | - | 15 | Jun 8, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintained: Buy | n/a | $53.99 | - | 19 | Jun 4, 2026 | |
| CABA Cabaletta Bio | Maintained: Buy | n/a | $3.02 | - | 27 | Jun 3, 2026 | |
| KYTX Kyverna Therapeutics | Maintained: Buy | n/a | $8.43 | - | 11 | Jun 3, 2026 | |
| KRYS Krystal Biotech | Maintained: Buy | n/a | $340.21 | - | 18 | May 18, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | n/a | $2.07 | - | 25 | May 14, 2026 | |
| SLDB Solid Biosciences | Maintained: Buy | n/a | $8.79 | - | 19 | May 13, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $24 → $32 | $33.20 | -3.61% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $27.01 | -30.58% | 1 | May 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.26 | - | 20 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.47 | - | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $56.50 | - | 13 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $82.13 | - | 41 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.76 | - | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $49.04 | - | 29 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.726 | - | 15 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $29.30 | - | 18 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.03 | - | 15 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.41 | - | 15 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.38 | n/a | 5 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.86 | n/a | 4 | Feb 1, 2023 |
Tyra Biosciences
Jun 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.06
Upside: -
Neurogene
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $30.86
Upside: -
Zevra Therapeutics
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $13.00
Upside: -
CRISPR Therapeutics AG
Jun 4, 2026
Maintained: Buy
Price Target: n/a
Current: $53.99
Upside: -
Cabaletta Bio
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $3.02
Upside: -
Kyverna Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $8.43
Upside: -
Krystal Biotech
May 18, 2026
Maintained: Buy
Price Target: n/a
Current: $340.21
Upside: -
Allogene Therapeutics
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $2.07
Upside: -
Solid Biosciences
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $8.79
Upside: -
Beam Therapeutics
May 7, 2026
Reiterated: Buy
Price Target: $24 → $32
Current: $33.20
Upside: -3.61%
May 2, 2026
Initiated Coverage: Buy
Price Target: $19
Current: $27.01
Upside: -30.58%
Feb 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.26
Upside: -
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $3.47
Upside: -
Feb 24, 2026
Maintained: Hold
Price Target: n/a
Current: $56.50
Upside: -
Feb 20, 2026
Maintained: Buy
Price Target: n/a
Current: $82.13
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: n/a
Current: $28.76
Upside: -
Feb 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $49.04
Upside: -
Jan 9, 2026
Maintained: Buy
Price Target: n/a
Current: $0.726
Upside: -
Nov 12, 2025
Maintained: Hold
Price Target: n/a
Current: $29.30
Upside: -
Nov 11, 2025
Maintained: Hold
Price Target: n/a
Current: $3.03
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $2.41
Upside: -
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $15.38
Upside: n/a
Feb 1, 2023
Maintained: Buy
Price Target: n/a
Current: $6.86
Upside: n/a